Research Canada

On the Move!
The Parliamentary
Health Research Caucus in 2017
Biotechnology in Health Research Reception
On Monday, October 16, 2017, Research Canada will host a Biotechnology in Health Research Reception from 3:30 pm to 6:30 pm on Parliament Hill. We are pleased to announce the following four Kiosk Themes and Researchers/Biotech Company Founders/CEOs who the Chair, Mr. John Oliver, MP Oakville, and Past Chair, Senator Kelvin K. Ogilvie and the NDP Representative, Ms. Carol Hughes, MP, Algoma-Manitoulin-Kapuskasing chose to present at our event and who are from Research Canada Member organizations:
Researchers, Innovators, their Projects and Companies
Harnessing the Social and Economic Potential of Biotech: Advances in Clinical Translation, Commercialization and Manufacturing

  • Dr. Stuart Foster, Senior Scientist, Sunnybrook Research Institute and Professor, Department of Medical Biophysics, University of Toronto and Founder, FUJIFILM VisualSonics (Ontario)
  • Dr. Michael May, President and CEO, CCRM and Founder and CEO, Rimon Therapeutics (Ontario)
  • Dr. John Bell, Senior Scientist, Centre for Innovative Cancer Research, OHRI and Professor, Depts. of Medicine and Biochemistry, Microbiology & Immunology, University of Ottawa and Scientific Director, BioCanRx (Ontario)

Biotechnology Solutions for Infectious Threats and Antimicrobial Resistance

  • Dr. Darryl Falzarano, Research Scientist, VIDO-InterVac and University of Saskatchewan (Saskatchewan)
  • Dr. Patrice Allibert, President and CEO, GenePOC Inc. (Québec)


Biotechnology Solutions for Non-communicable Diseases: Advances in Cell Therapy, Regenerative Medicine and Nanotechnology

  • Dr. Gang Zheng, Professor, University of Toronto, and Senior Scientist and Core Lead, University Health Network (Ontario)
  • Dr. Mark Brandon, Assistant Professor and Canada Research Chair in the Neural Circuits of Memory, Douglas Hospital Research Center and McGill University (Québec)
  • Dr. Timothy Kieffer, Professor, Cellular & Physiological Sciences and Surgery, and MSFHR Senior Scholar, University of British Columbia (British Columbia)
  • Dr. Dave Stojdl, Professor, University of Ottawa and Principal Investigator, CHEO Research Institute and Co-founder, Turnstone Biologics (Ontario)


The Revolution in Precision Medicine: Data, Diagnostics and Personalized Care

  • Dr. Chun Peng, Principal Investigator and Professor, Department of Biology, York University, York Research Chair in Women’s Reproductive Health, Tier 1 (Ontario)
  • Dr. Jeff Carson, Associate Professor, Schulich School of Medicine & Dentistry, Western University and Scientist, Lawson Health Research Institute (Ontario)
  • Dr. James Kennedy, Full Professor, Department of Psychiatry, University of Toronto and Head of the Tanenbaum Centre for Pharmacogenetics, CAMH, (Ontario)
  • Dr. Andrew Vieira, Chair of Sanofi Genzyme Medical Affairs, Sanofi Genzyme (Ontario)

more researchers and innovator to be confirmed shortly…

We wish to thank all of our highly-valued Members who submitted names to us. There will be a lot of other opportunities to profile your researchers and institutions in 2018 for both our Chronic Disease and Northern and Rural Health Research events. More to come.

Celebrating Our Gairdners
Research Canada, in partnership with the Gairdner Foundation, will host a private luncheon in the Parliamentary restaurant on October 24, 2017 with the Parliamentary Health Research Caucus Chair, Past Chair and NDP Representative, select Parliamentarians and two of the 2017 Gairdner Awardees: Dr. Cesar Victora, Emeritus Professor, Federal University of Pelotas, Pelotas, Brazil and Dr. Antoine M. Hakim, Emeritus Professor, Neurology, University of Ottawa, Ontario, Canada.
Stem Cell Research Luncheon
Dr. Tim Caulfield is a Stem Cell Network investigator and internationally known for his work on stem cell tourism. He is a Canada Research Chair in Health Law and Policy, a Professor in the Faculty of Law and the School of Public Health, and Research Director of the Health Law Institute at the University of Alberta. Dr. Lauralyn McIntyre, a clinician scientist at the Ottawa Hospital, is leading a world class clinical trial on septic shock, using a novel stem cell therapy. Each year 100,000 Canadians contract septic shock. This illness can be fatal with up to 40 percent of patients dying. Unfortunately, often those who survive experience severe long-term effects. The estimated annual cost on the health care system is an estimated $4 billion. Dr. McIntyre’s phase II trial, funded by the Stem Cell Network is showing significant promise.
 
Drs. Caulfield and McIntyre will be keynote speakers at Research Canada’s Parliamentary Health Research Caucus Luncheon on Stem Cell Research on December 5, 2017 and will demonstrate that through stem cell research and regenerative medicine safe, reliable and effective therapies can and will be widely available in the coming decades.
Indigenous Health Research Reception
Research Canada’s Parliamentary Health Research Caucus Reception on Indigenous Health Research in Canada, held on Monday, June 5, 2017 was extremely well attended by Parliamentarians including the Honourable Carolyn Bennett, Minister of Indigenous and Northern Affairs and the Honourable Jane Philpott, Minister of Health. We were delighted to welcome Dr. Carrie Bourassa, Scientific Director of CIHR’s Institute of Aboriginal Peoples’ Health as a Guest Speaker as well as Dr. Janet McElhaney from Health Sciences North.

Please see a short video presentation of the event here.

We were grateful for the Diamond sponsorship of Health Sciences North Research Institute, Platinum sponsorship of Roche Diagnostics Canada and the ongoing tremendous contributions of our Parliamentary Health Research Caucus Lead Sponsor, Innovative Medicines Canada.

Thank you to all the sponsors for this event, including:

silver sponsors AstraZeneca Canada, Dalhousie University, Merck, Simon Fraser
University, Heart and Stroke Foundation.

bronze sponsors Holland Bloorview Kids Rehabilitation Hospital, Concordia
University,Faculty of Health Sciences at the University of Ontario Institute of Technology, McMaster Universit,The Michener Institute of Education at UHN,Thunderbird Partnership Foundation, University Health Network (UHN)

and contributing sponsors Canadian Association for Long Term Care (CALTC), Canadian Association for Neuroscience (CAN), Canadian Association for Nursing Research (CANR), Canadian Nurses Association (CNA), Canadian Nurses Foundation (CNF), Canadian Society for Medical Laboratory Science (CSMLS), Chronic Pain Network (CPN), GlaxoSmithKline (GSK), Genome Canada, HealthCareCAN, Hill + Knowlton Strategies, Indigenous Peoples’ Health Research Centre (IPHRC), IWK Health Centre, Lakehead University, Lord Elgin Hotel, Novo Nordisk Canada, Providence Health Care Research Institute (PHCRI), The Royal’s Institute of Mental Health Research (IMHR), Thunder Bay Regional Health Research Institute (TBRHRI), The University of Ottawa.

FINA Submission

 

In line with Research Canada’s mandate, we are of the view that investments in basic scientific research, as described in this year’s Fundamental Science Review, led by Dr. C. David Naylor, are critical to ensuring the long-term productivity of Canadians and Canadian businesses. In our view, we cannot have a conversation about measures to support Canadian productivity and competitiveness without recognizing the central position played by fundamental science within Canada’s innovation engine, key to Canada’s current and future economic success. Thus, in Research Canada’s 2017 submission to the House of Commons Standing Committee on Finance, we will be recommending:

  • Increased
    investment of $485 million over four years to fund investigator-led research;
  • Stable
    funding of $300 million annually for the Canada Foundation for Innovation (CFI);
  • Enhanced
    support for doctoral students, postdoctoral fellows, and research chairs;
  • New
    support for small capital grants, as well as for the infrastructure and
    equipment costs associated with federally-funded research;
  • Financial
    support to diversify opportunities for science-based graduate students so that
    they may explore, embrace and compete for non-academic careers in order to
    capitalize fully on their talent and energy. Such opportunities would be
    achieved through new academic programs created through formal partnerships
    among universities, colleges, academic health science centres, health charities
    and Canadian industries to increase graduate students’ opportunities to
    participate in cooperative and internship programs.

Over the next few weeks we will be meeting with key decision makers and joining our R10 Partners and health research and health innovation advocates to make the case for this level of investment in investigator-led research. Once our submission is finalized it will be on our website www.rc-rc.ca.

Leadership in Advocacy Award

Research Canada’s 2017 Leadership Awardee(s)
have been chosen!  Thank you to all of
our Members, Supporters and Partners for the excellent roster of candidates for
this year’s award. The Leadership Award Selection Committee was extremely
impressed with this year’s sixteen candidates! The award(s) will be presented
in Montreal on November 22, 2017. This year’s winner(s) will be announced the
same day. Stay tuned…
Catalogue of Products and Services: Calling All Suppliers


Research Canada is asking its highly-valued
Members for supplier recommendations for its Member Catalogue of Products and
Services. Please tell us which suppliers you use frequently and we will contact
them and provide them with free advertising in our Catalogue in return for
discount savings on their services which we will pass along to you as our
highly-valued Member. Help us to help you save money! Please contact dmacarthur@rc-rc.ca
HRI Portal: Save Significantly on Media Release Distribution

Research
Canada is pleased to be offering its Members, Partners and Supporters free
Media Monitoring services through its HRI Portal. To subscribe to our RSS feed
and receive current news on health research and health innovation in Canada,
please visit: www.hriportal.ca or
subscribe to our media monitoring list via email at media@hriportal.ca.
 
We are
also offering a media release distribution service at a fraction of the cost of
traditional newswire services. The HRI Portal is tailored to our Members,
Supporters and Partners and targets health and science journalists
specifically.

For more
information, please contact us at: media@hriportal.ca.
The Media Portal of Research Canada helped promote the World Health Summit held in Montreal held in May 2017. Sponsored in part by the Institut de recherches cliniques de Montréal (IRCM)/Montreal Clinical Research Institute, this communication tool was very useful to publicize this international summit and to enhance the visibility of our institute. As a member of Research Canada, it is a definitively huge advantage.”
 
                                                Dr. Tarik Möröy. President and Scientific Director
Montreal Clinical Research Institute
 

 


News from the Portal

hriportal.ca

 

 

People living in rural households have lower risk of developing inflammatory bowel disease: study

CHEO-led project secures worldwide consensus on the terminology that supports research into sedentary behavior

Research Canada Celebrates Leadership in Indigenous Health Research and Health Research Advocacy

Brain cancer research led in Ontario gets a $10M boost

Inflammatory bowel diseases on the rise in very young Canadian children

Report on Fundamental Science Presents a Bold Plan to Reinvigorate Canadian Research

Gairdner prize for Lewis Kay underlines importance of support for fundamental science

Budget 2017 falls short in support for discovery research

Budget 2017: Important Health and Innovation Investments with Uncertainty for Fundamental Science

Seeking early-career researchers with big ideas focused on the prevention and treatment of mental illness

Researchers Brief Parliamentarians on Neurological Conditions that Cause Significant Economic Burden

Ottawa researchers kill brain cancer in mice with combination immunotherapies